Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
Yang K, Hu H, Wu J, Wang H, Guo Z, Yu W, Yao L, Ding F, Zhou T, Wang W, Wang Y, Liu L, Guo J, Zhu S, Zhang X, Cao S, Lou F, Niu Y, Ye D, He Z.
Yang K, et al. Among authors: zhang x.
Mol Cancer. 2023 Feb 4;22(1):25. doi: 10.1186/s12943-023-01729-7.
Mol Cancer. 2023.
PMID: 36739413
Free PMC article.